Loteprednol
Systematic (IUPAC) name | |
---|---|
Chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate | |
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a606003 |
Pregnancy category |
|
Legal status |
|
Identifiers | |
CAS Number | 82034-46-6 |
ATC code | S01BA14 |
PubChem | CID 444025 |
IUPHAR/BPS | 7085 |
DrugBank | DB00873 |
ChemSpider | 392049 |
UNII | Z8CBU6KR16 |
KEGG | D01689 |
ChEMBL | CHEMBL1201389 |
Chemical data | |
Formula | C24H31ClO7 |
Molar mass | 466.951 g/mol |
(what is this?) (verify) |
Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used in ophthalmology. Marketed by Bausch and Lomb as Lotemax in the U.S., ocular applications for this drug include the treatment of inflammation of the eye due to allergies (according to the prescription information sheet), as well as chronic forms of keratitis (e.g.: adenoviral and Thygeson’s keratitis), vernal keratoconjunctivitis, pingueculitis, and episcleritis. The drug has little or no effect on intraocular pressure.
See also
References
- Steward, R; et al. (November 1998). "Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation". J Cataract Surg 24: 1480–1489.
- Pavesio, CE; Decory, HH (2008). "Treatment of ocular inflammatory conditions with loteprednol etabonate". Br J Ophthalmol 92 (4): 455–459. doi:10.1136/bjo.2007.132621. PMID 18245274.
|
Español
This article is issued from Wikipedia - version of the Friday, December 18, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.